Kentucky Department for Public Health announces COVID-19 vaccine distribution draft plan

In a draft document framework released last month, the US National Academies of Sciences, Engineering and Medicine said only 10 million to 15 million doses of a vaccine may be available initially, which may cover only 3 to 5 per cent of the US population. "Right now, we don't know when that might be". They aim to deliver tens of millions of doses in the United States by the end of the year. It won't make COVID-19 magically disappear overnight.

"WASHINGTON" The US pharmaceutical giant Pfizer expects to file for emergency use authorisation for its Covid-19 vaccine in late November, around two weeks after the Nov 3 US presidential election, it said on Friday.

Chief executive Albert Bourla wrote in the letter that while the company projects it may have effectiveness data in October, there will not be sufficient safety data to satisfy criteria laid out by the Food and Drug Administration until late November.

The state said it plans to distribute the vaccines in the spring.

MA says it expects to receive between 20,000 and 60,000 doses of vaccines in phase one. "While there is work to be done, the submission of this document represents a positive step forward". Dr. Nirav Shah said the guiding principles behind the state's approach are equity, accessibility and flexibility. His company is one of the leaders in the work of making a vaccine that could protect people from the virus. For instance, some vaccine candidates need cold storage and two doses.

Pfizer to seek emergency approval for COVID vaccine next month

The US agency, which is rising the vaccine along with Germany's BioNTech SE, has mentioned it'd perceive on the finish of the month whether or not its merchandise was highly effective. "Will they require a minus 70 degree freezer, or a normal freezer?"

The state is calling on Congress to provide immediate funding for states to implement COVID-19 vaccine distribution plans. The pandemic has sickened more than 5,800 people in ME and claimed 145 lives.

The Baker administration says even 60,000 doses won't be enough to cover all of the priority groups, so hospitals and long-term care facilities will need to create their own lists of providers and patients who will be inoculated first.

The change comes into force after a consultation on the plans, which include giving Britain's medical regulator the ability to grant temporary authorisation for any coronavirus vaccine that meets safety and quality standards but before it has received a full licence. And unlike vaccines against other diseases such as measles, experts believe Covid-19 vaccines, when they come, will fall far short of being 100 percent effective.